MD ANDERSON CANCER CENTER and Memorial Hermann Health System formed a partnership to provide specialized breast screening at a network of community breast care centers in the greater Houston area.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
